prednisone has been researched along with Malignant Melanoma in 71 studies
Prednisone: A synthetic anti-inflammatory glucocorticoid derived from CORTISONE. It is biologically inert and converted to PREDNISOLONE in the liver.
prednisone : A synthetic glucocorticoid drug that is particularly effective as an immunosuppressant, and affects virtually all of the immune system. Prednisone is a prodrug that is converted by the liver into prednisolone (a beta-hydroxy group instead of the oxo group at position 11), which is the active drug and also a steroid.
Excerpt | Relevance | Reference |
---|---|---|
" Here, we report a case of a 75-year-old man with myasthenia gravis and metastatic melanoma who experienced complete and durable systemic regression after receiving pembrolizumab and single-lesion RT while on prednisone for myasthenia gravis prophylaxis and vedolizumab for immune-mediated colitis after previously experiencing mixed response on pembrolizumab monotherapy." | 5.12 | Durable Metastatic Melanoma Remission Following Pembrolizumab and Radiotherapy: A Case Report of Prophylactic Immunosuppression in a Patient with Myasthenia Gravis and Immune-Mediated Colitis. ( Clark, CA; Deshane, AS; Dobelbower, MC; Moradi, LA; Schneider, CS, 2021) |
"We describe two cases of CIDP secondary to treatment with combined ipilimumab and nivolumab in patients with metastatic melanoma that were successfully treated with prednisone and IVIG." | 3.91 | Chronic inflammatory demyelinating polyradiculoneuropathy secondary to immune checkpoint inhibitors in melanoma patients. ( Patel, AS; Sehdev, A; Snook, RJ, 2019) |
" ICIs initate antitumor immunity; however, these agents are associated with immune-related adverse events (irAEs) that may affect a variety of organs." | 2.61 | Diagnosis and Management of Immune Checkpoint Inhibitor-Associated Renal Toxicity: Illustrative Case and Review. ( Reynolds, KL; Seethapathy, H; Sise, ME, 2019) |
"ICIs can cause rheumatic adverse events, resulting in decreased quality of life that may require immunesuppressive treatment." | 1.91 | [Rheumatic adverse events due to immune checkpoint inhibitors]. ( Heslinga, SC; Labots, M; Lems, WF; Tsang-A-Sjoe, MWP; van Binsbergen, WH; van der Laken, J, 2023) |
"Eosinophilia has been reported as a rare, new biological effect of immune checkpoint inhibition that may be associated with improved treatment response and the development of immune-related adverse events." | 1.51 | Dual checkpoint inhibitor-associated eosinophilic enteritis. ( Carvajal, RD; Lagana, SM; Saenger, YM; Yang, J, 2019) |
"Colitis was defined by diarrhea (grade≥2) requiring steroids with or without endoscopic/histologic/radiologic evidence of colitis." | 1.42 | Ipilimumab-induced colitis in patients with metastatic melanoma. ( De Felice, KM; Finnes, HD; Gupta, A; Khanna, S; Kottschade, LA; Loftus, EV; Markovic, SN; Papadakis, KA; Raffals, LE; Rakshit, S, 2015) |
"Eosinophilic fasciitis (EF) is a rare inflammatory and fibrosing disorder with clinical, biological and histological characteristics." | 1.35 | [Eosinophilic fasciitis and metastatic choroïdal melanoma: a paraneoplastic syndrome?]. ( Dendale, R; Lumbroso-Le Rouic, L; Récanati, G; Veyssier-Belot, C; Zuech, P, 2008) |
"We report a case of disseminated superficial actinic porokeratosis (DSAP) with neutrophilic pustules within cornoid lamellae on histopathologic examination, corresponding to pustules along the elevated rim clinically as well." | 1.35 | Pustular porokeratosis. ( Miller, DD; Ruben, BS, 2009) |
"Opsoclonus-myoclonus is a well-described paraneoplastic syndrome that most often occurs in association with small cell carcinoma of the lung and breast carcinoma." | 1.30 | Paraneoplastic opsoclonus-myoclonus secondary to malignant melanoma. ( Berger, JR; Mehari, E, 1999) |
"Leukocytosis has been noted in association with many non-hematologic malignancies in the absence of concurrent infection or metastatic involvement of bone marrow." | 1.27 | Leukocytosis due to adrenal metastases from malignant melanoma: reversal after bilateral adrenalectomy with long-term survival. ( Carey, RW; Kunz, VS, 1988) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 18 (25.35) | 18.7374 |
1990's | 7 (9.86) | 18.2507 |
2000's | 8 (11.27) | 29.6817 |
2010's | 29 (40.85) | 24.3611 |
2020's | 9 (12.68) | 2.80 |
Authors | Studies |
---|---|
Moradi, LA | 1 |
Clark, CA | 1 |
Schneider, CS | 1 |
Deshane, AS | 1 |
Dobelbower, MC | 1 |
Habibi, S | 1 |
Soliman, A | 1 |
Dasanu, CA | 1 |
van Binsbergen, WH | 1 |
Heslinga, SC | 1 |
Lems, WF | 1 |
Tsang-A-Sjoe, MWP | 1 |
Labots, M | 1 |
van der Laken, J | 1 |
Yang, J | 1 |
Lagana, SM | 1 |
Saenger, YM | 1 |
Carvajal, RD | 1 |
Navarro-Perea, C | 1 |
Garcia-Gonzalez, J | 1 |
Perez-Blazquez, E | 1 |
Patel, AS | 1 |
Snook, RJ | 1 |
Sehdev, A | 1 |
Taillefer, VT | 1 |
Pigeon, M | 1 |
Chen, M | 2 |
Larochelle, C | 1 |
Florescu, M | 1 |
Bélanger, K | 1 |
Adam, JP | 1 |
Yaşar, HA | 1 |
Akkus, E | 1 |
Heper, A | 1 |
Akay, BN | 1 |
Urun, Y | 1 |
Utkan, G | 1 |
Calvani, J | 1 |
Elia, R | 1 |
Battistella, M | 1 |
Delyon, J | 1 |
Vivier-Chicoteau, J | 1 |
Gornet, JM | 1 |
Lebbé, C | 1 |
Baroudjian, B | 1 |
Bertheau, P | 1 |
Liu, H | 1 |
Kuang, X | 1 |
Zhang, Y | 1 |
Ye, Y | 1 |
Li, J | 1 |
Liang, L | 1 |
Xie, Z | 1 |
Weng, L | 1 |
Guo, J | 1 |
Li, H | 1 |
Ma, F | 1 |
Chen, X | 2 |
Zhao, S | 1 |
Su, J | 1 |
Yang, N | 1 |
Fang, F | 1 |
Xie, Y | 1 |
Tao, J | 1 |
Zhang, J | 1 |
Peng, C | 1 |
Sun, L | 1 |
Zhang, X | 1 |
Liu, J | 1 |
Han, L | 1 |
Xu, X | 1 |
Hung, MC | 1 |
Morris, LM | 1 |
Lewis, HA | 1 |
Cornelius, LA | 1 |
Chen, DY | 1 |
Rosman, IS | 1 |
Okoye, IS | 1 |
Xu, L | 1 |
Walker, J | 1 |
Elahi, S | 1 |
Jain, A | 1 |
Lipson, EJ | 2 |
Sharfman, WH | 2 |
Brant, SR | 1 |
Lazarev, MG | 1 |
Kanno, H | 1 |
Ishida, K | 1 |
Yamada, W | 1 |
Nishida, T | 1 |
Takahashi, N | 1 |
Mochizuki, K | 1 |
Mizuno, Y | 1 |
Matsuyama, K | 1 |
Takahashi, T | 1 |
Seishima, M | 1 |
Maeda, T | 1 |
Yanagi, T | 1 |
Imafuku, K | 1 |
Kitamura, S | 1 |
Hata, H | 1 |
Izumi, K | 1 |
Ujiie, H | 1 |
Iwata, H | 1 |
Shimizu, H | 1 |
Sun, Y | 1 |
Lee, SK | 1 |
Oo, TH | 1 |
Rojas-Hernandez, CM | 1 |
Amber, KT | 1 |
Valdebran, M | 1 |
Lu, Y | 1 |
De Feraudy, S | 1 |
Linden, KG | 1 |
Ngo, L | 1 |
Miller, E | 1 |
Valen, P | 1 |
Gertner, E | 1 |
Amini-Adle, M | 1 |
Piperno, M | 1 |
Tordo, J | 1 |
Thomas, L | 1 |
Dalle, S | 1 |
Dubois, V | 1 |
Marabelle, A | 1 |
Arays, R | 1 |
Wang, P | 1 |
Sadaat, M | 1 |
Jang, S | 1 |
Jespersen, H | 1 |
Bjursten, S | 1 |
Ny, L | 1 |
Levin, M | 1 |
Boiché, M | 1 |
Conart, JB | 1 |
Angioi-Duprez, K | 1 |
Cheng, MW | 1 |
Hisaw, LD | 1 |
Bernet, L | 1 |
Rao, BB | 1 |
Robertson, S | 1 |
Philpott, J | 1 |
Sise, ME | 1 |
Seethapathy, H | 1 |
Reynolds, KL | 1 |
Klein, O | 1 |
Ribas, A | 1 |
Chmielowski, B | 1 |
Walker, G | 1 |
Clements, A | 2 |
Long, GV | 1 |
Kefford, RF | 1 |
Anderson, L | 1 |
Bhatia, V | 1 |
Bodell, MA | 1 |
Kraus, ES | 1 |
Kyllo, RL | 1 |
Parker, MK | 1 |
Rosman, I | 1 |
Musiek, AC | 1 |
Fonollosa, A | 1 |
Mesquida, M | 1 |
Adan, A | 1 |
Carlos, G | 1 |
Anforth, R | 1 |
Chou, S | 1 |
Fernandez-Peñas, P | 1 |
De Felice, KM | 1 |
Gupta, A | 1 |
Rakshit, S | 1 |
Khanna, S | 1 |
Kottschade, LA | 1 |
Finnes, HD | 1 |
Papadakis, KA | 1 |
Loftus, EV | 1 |
Raffals, LE | 1 |
Markovic, SN | 1 |
Klair, JS | 1 |
Girotra, M | 1 |
Hutchins, LF | 1 |
Caradine, KD | 1 |
Aduli, F | 1 |
Garcia-Saenz-de-Sicilia, M | 1 |
Veyssier-Belot, C | 1 |
Zuech, P | 1 |
Lumbroso-Le Rouic, L | 1 |
Récanati, G | 1 |
Dendale, R | 1 |
Miller, DD | 1 |
Ruben, BS | 1 |
Balachandran, I | 1 |
Walker, JW | 1 |
Broman, J | 1 |
Yu, GH | 1 |
Qu, GM | 1 |
Yao, WD | 1 |
Lang, ZQ | 1 |
Wang, W | 1 |
Fontanilla, FA | 1 |
Edward, DP | 1 |
Wong, M | 1 |
Tessler, HH | 1 |
Eagle, RC | 1 |
Goldstein, DA | 1 |
Xu, XF | 1 |
Zhang, XJ | 1 |
Schoenberger, SD | 1 |
Kim, SJ | 1 |
Lavin, P | 1 |
Li, XX | 1 |
Sang, W | 1 |
Zhang, W | 1 |
Shi, XL | 1 |
Gulinaer, A | 1 |
Yang, WT | 1 |
KAUFMAN, HE | 1 |
Liu, JK | 1 |
Kan, P | 1 |
Schmidt, MH | 1 |
Siegelmann-Danieli, N | 1 |
Bardo, M | 1 |
Law, A | 1 |
Fisk, D | 1 |
Bernath, A | 1 |
Wendling, D | 1 |
Aubin, F | 1 |
McQuillen, MP | 1 |
Norrell, H | 1 |
Czarnetzki, BM | 1 |
Macher, E | 1 |
Cuchural, GJ | 1 |
Levey, AS | 1 |
Pauker, SG | 1 |
Kaufmann, B | 1 |
Wegmann, W | 1 |
Lanza, L | 1 |
Peirano, L | 1 |
Bosco, O | 1 |
Contini, P | 1 |
Filaci, G | 1 |
Setti, M | 1 |
Puppo, F | 1 |
Indiveri, F | 1 |
Scudeletti, M | 1 |
Tucker, SM | 1 |
Hurwitz, JJ | 1 |
Pavlin, CJ | 1 |
Howarth, DJ | 1 |
Nianiaris, N | 1 |
Falk, S | 1 |
Walther, F | 1 |
Denk, R | 1 |
Szepietowski, J | 1 |
Wasik, F | 1 |
Szepietowski, T | 1 |
Włodarczyk, M | 1 |
Sobczak-Radwan, K | 1 |
Czyz, W | 1 |
Gündüz, K | 1 |
Shields, CL | 1 |
Shields, JA | 1 |
Schubert, H | 1 |
Berger, JR | 1 |
Mehari, E | 1 |
Creager, AJ | 1 |
Geisinger, KR | 1 |
Bergman, S | 1 |
Mérot, Y | 1 |
Miescher, PA | 1 |
Balsiger, F | 1 |
Magnenat, P | 1 |
Frenk, E | 1 |
Borden, EC | 1 |
Hawkins, MJ | 1 |
Eisner, SB | 1 |
Mitnick, PD | 1 |
Carey, RW | 1 |
Kunz, VS | 1 |
Tashima, CK | 1 |
Jaffe, N | 1 |
Traggis, D | 1 |
Das, L | 1 |
Moloney, WC | 1 |
Hann, HW | 1 |
Kim, BS | 1 |
Nair, R | 1 |
Mathé, G | 1 |
Amiel, JL | 1 |
Clarysse, A | 1 |
Hayat, M | 1 |
Schwarzenberg, L | 1 |
Carter, SK | 1 |
Gutterman, JU | 1 |
Mavligit, GM | 1 |
Reed, RC | 1 |
Hersh, EM | 1 |
Manny, N | 1 |
Rosenman, E | 1 |
Benbassat, J | 1 |
Gottlieb, JA | 1 |
Frei, E | 1 |
Luce, JK | 1 |
Birge, HL | 1 |
Gilbert, TT | 1 |
Evjy, JT | 1 |
Edelstein, L | 1 |
Ryan, SJ | 1 |
Frank, RN | 1 |
Green, WR | 1 |
9 reviews available for prednisone and Malignant Melanoma
Article | Year |
---|---|
Durable Metastatic Melanoma Remission Following Pembrolizumab and Radiotherapy: A Case Report of Prophylactic Immunosuppression in a Patient with Myasthenia Gravis and Immune-Mediated Colitis.
Topics: Aged; Antibodies, Monoclonal, Humanized; Chemoradiotherapy; Colitis; Humans; Immune Checkpoint Inhib | 2021 |
Hemophagocytic lymphohistiocytosis with immunotherapy: brief review and case report.
Topics: Antibodies, Monoclonal, Humanized; Antineoplastic Agents, Immunological; Humans; Immunotherapy; Lymp | 2018 |
Diagnosis and Management of Immune Checkpoint Inhibitor-Associated Renal Toxicity: Illustrative Case and Review.
Topics: Acute Kidney Injury; Anti-Inflammatory Agents; Antineoplastic Agents, Immunological; Disease Managem | 2019 |
Ipilimumab-associated Sweet syndrome in a patient with high-risk melanoma.
Topics: Aged; Antibodies, Monoclonal; Biopsy, Needle; Chemotherapy, Adjuvant; Dapsone; Female; Follow-Up Stu | 2014 |
THE UVEA.
Topics: Anatomy; Arthritis; Autoantibodies; Betamethasone; Dexamethasone; Dihydroxyphenylalanine; Epidemiolo | 1964 |
[Metastatic malignant melanoma in treated non-Hodgkin's lymphoma].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Chlorambucil; Humans; Lymph Nodes; Lymphatic | 1996 |
Biologic response modifiers as adjuncts to other therapeutic modalities.
Topics: Adjuvants, Immunologic; Animals; Antineoplastic Combined Chemotherapy Protocols; BCG Vaccine; Breast | 1986 |
An overview of the status of the nitrosoureas in other tumors.
Topics: Adenocarcinoma; Alkylating Agents; Antineoplastic Agents; Breast Neoplasms; Carcinoma; Carcinoma, Br | 1973 |
Immunochemotherapy of human cancer.
Topics: Acute Disease; Adjuvants, Immunologic; Adult; Animals; Antineoplastic Agents; BCG Vaccine; Cytarabin | 1974 |
1 trial available for prednisone and Malignant Melanoma
Article | Year |
---|---|
Biologic response modifiers as adjuncts to other therapeutic modalities.
Topics: Adjuvants, Immunologic; Animals; Antineoplastic Combined Chemotherapy Protocols; BCG Vaccine; Breast | 1986 |
62 other studies available for prednisone and Malignant Melanoma
Article | Year |
---|---|
Cycle-dependent eosinophilia due to adjuvant nivolumab for malignant melanoma.
Topics: Aged; Antineoplastic Agents, Immunological; Eosinophilia; Humans; Male; Melanoma; Melanoma, Cutaneou | 2023 |
[Rheumatic adverse events due to immune checkpoint inhibitors].
Topics: Aged; Arthritis; Female; Humans; Immune Checkpoint Inhibitors; Male; Melanoma; Middle Aged; Nivoluma | 2023 |
Dual checkpoint inhibitor-associated eosinophilic enteritis.
Topics: Aged; Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; Enteriti | 2019 |
Case report: Bilateral uveitis and papillitis secondary to treatment with pembrolizumab.
Topics: Adult; Antibodies, Monoclonal, Humanized; Antineoplastic Agents, Immunological; Drug Combinations; D | 2019 |
Chronic inflammatory demyelinating polyradiculoneuropathy secondary to immune checkpoint inhibitors in melanoma patients.
Topics: Aged; Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; Female; | 2019 |
Very high-dose methylprednisolone for treatment of nivolumab-induced limbic encephalitis: A case report.
Topics: Aged; Autoimmune Diseases; Humans; Limbic Encephalitis; Male; Melanoma; Methylprednisolone; Nivoluma | 2020 |
Sweet's syndrome under ipilimumab therapy and a brief comparison of the cases in literature.
Topics: Biopsy; CTLA-4 Antigen; Female; Humans; Ipilimumab; Melanoma; Middle Aged; Prednisone; Skin Neoplasm | 2020 |
[An unusual digestive complication under anti-PD-1 (pembrolizumab)].
Topics: Aged; Antibodies, Monoclonal, Humanized; Budesonide; Colitis, Collagenous; Diarrhea; Humans; Hypokal | 2020 |
ADORA1 Inhibition Promotes Tumor Immune Evasion by Regulating the ATF3-PD-L1 Axis.
Topics: Activating Transcription Factor 3; Adenosine A1 Receptor Antagonists; Adult; Aged; Animals; Antineop | 2020 |
Neutrophil-predominant bullous pemphigoid induced by checkpoint inhibitors: A case series.
Topics: Aged; Antimalarials; Dapsone; Drug Eruptions; Drug Therapy, Combination; Glucocorticoids; Humans; Im | 2020 |
The glucocorticoids prednisone and dexamethasone differentially modulate T cell function in response to anti-PD-1 and anti-CTLA-4 immune checkpoint blockade.
Topics: Antibodies, Monoclonal; Antineoplastic Combined Chemotherapy Protocols; CTLA-4 Antigen; Dexamethason | 2020 |
Colonic ulcerations may predict steroid-refractory course in patients with ipilimumab-mediated enterocolitis.
Topics: Administration, Intravenous; Adrenal Cortex Hormones; Antibodies, Monoclonal; Antineoplastic Agents; | 2017 |
Uveitis induced by programmed cell death protein 1 inhibitor therapy with nivolumab in metastatic melanoma patient.
Topics: Administration, Ophthalmic; Antibodies, Monoclonal; Antineoplastic Agents; Betamethasone; Female; Gl | 2017 |
Using immune checkpoint inhibitors without exacerbation in a melanoma patient with pemphigus foliaceus.
Topics: Aged; Anti-Inflammatory Agents; Antineoplastic Agents, Immunological; Fatal Outcome; Female; Humans; | 2017 |
Management of Immune-mediated Cytopenias in the Era of Cancer Immunotherapy: A Report of 4 Cases.
Topics: Anemia, Hemolytic; Antibodies, Monoclonal, Humanized; CTLA-4 Antigen; Drug-Related Side Effects and | 2018 |
Localized pretibial bullous pemphigoid arising in a patient on pembrolizumab for metastatic melanoma.
Topics: Administration, Oral; Administration, Topical; Aged, 80 and over; Antibodies, Monoclonal, Humanized; | 2018 |
Nivolumab induced remitting seronegative symmetrical synovitis with pitting edema in a patient with melanoma: a case report.
Topics: Administration, Oral; Aged; Antibodies, Monoclonal; Antineoplastic Agents; Edema; Glucocorticoids; H | 2018 |
Remitting Seronegative Symmetric Synovitis With Pitting Edema Associated With Partial Melanoma Response Under Anti-CTLA-4 and Anti-Programmed Death 1 Combination Treatment.
Topics: Aged; Antineoplastic Agents, Immunological; CTLA-4 Antigen; Edema; Glucocorticoids; Humans; Ipilimum | 2018 |
A case of pembrolizumab-induced localized organizing pneumonia.
Topics: Antibodies, Monoclonal, Humanized; Brain; Cryptogenic Organizing Pneumonia; Drug-Related Side Effect | 2018 |
Checkpoint inhibitor-induced sarcoid reaction mimicking bone metastases.
Topics: Antibodies, Monoclonal, Humanized; Antineoplastic Agents, Immunological; Bone Neoplasms; Diagnosis, | 2018 |
[Severe panuveitis in a metastatic cutaneous melanoma patient treated with vemurafenib].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Dose-Response Relationship, Drug; Female; Huma | 2018 |
Generalized morphea in the setting of pembrolizumab.
Topics: Antibodies, Monoclonal, Humanized; Antineoplastic Agents, Immunological; Biopsy; Choroid Neoplasms; | 2019 |
Checkpoint Inhibitor-Induced Hemorrhagic Gastritis with Pembrolizumab.
Topics: Adult; Anti-Inflammatory Agents; Antibodies, Monoclonal, Humanized; Antineoplastic Agents, Immunolog | 2019 |
Facial palsy as a side effect of vemurafenib treatment in patients with metastatic melanoma.
Topics: Antineoplastic Agents, Hormonal; Facial Paralysis; Humans; Indoles; Male; Melanoma; Middle Aged; Pre | 2013 |
Ipilimumab immune-related adverse reactions: a case report.
Topics: Antibodies, Monoclonal; Autoimmune Diseases; Female; Follow-Up Studies; Humans; Hydrocortisone; Hypo | 2013 |
Successful administration of ipilimumab to two kidney transplantation patients with metastatic melanoma.
Topics: Administration, Oral; Aged; Antibodies, Monoclonal; Antineoplastic Agents; Dacarbazine; Drug Adminis | 2014 |
Uveitic macular oedema after treatment with vemurafenib.
Topics: Adult; Aged; Antineoplastic Agents; Dexamethasone; Drug Implants; Glucocorticoids; Humans; Indoles; | 2015 |
A case of bullous pemphigoid in a patient with metastatic melanoma treated with pembrolizumab.
Topics: Aged; Anti-Inflammatory Agents; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Dexamethas | 2015 |
Ipilimumab-induced colitis in patients with metastatic melanoma.
Topics: Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal; Antineoplastic Agents; Budesonide; Colitis; | 2015 |
Ipilimumab-Induced Gastrointestinal Toxicities: A Management Algorithm.
Topics: Aged, 80 and over; Anti-Inflammatory Agents; Antibodies, Monoclonal; Colitis; Female; Gastrointestin | 2016 |
[Eosinophilic fasciitis and metastatic choroïdal melanoma: a paraneoplastic syndrome?].
Topics: Administration, Oral; Adrenal Cortex Hormones; Aged; Aged, 80 and over; Anti-Inflammatory Agents; An | 2008 |
Pustular porokeratosis.
Topics: Antimetabolites, Antineoplastic; Azathioprine; Colitis, Ulcerative; Diabetes Mellitus, Type 2; Human | 2009 |
Fine needle aspiration cytology of ALK1(-), CD30+ anaplastic large cell lymphoma post renal transplantation: a case report and literature review.
Topics: Adult; Anaplastic Lymphoma Kinase; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor | 2010 |
[Intravascular large B-cell lymphoma: report of a case].
Topics: Antigens, CD20; Antigens, CD34; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Di | 2009 |
Juvenile xanthogranuloma masquerading as melanoma.
Topics: Anti-Inflammatory Agents; Antineoplastic Agents, Alkylating; Child; Chlorambucil; Cyclosporine; Diag | 2009 |
[Extranodal follicular dendritic cell sarcoma of neck region: report of a case].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Cyclophosphamide; Dendritic Cell Sarcoma, | 2012 |
Paraneoplastic optic neuropathy from cutaneous melanoma detected by positron emission tomographic and computed tomographic scanning.
Topics: Aged; Combined Modality Therapy; Female; Fluorescein Angiography; Humans; Lymph Node Excision; Lymph | 2012 |
[Clinicopathologic study of 20 cases of anaplastic large-cell lymphoma].
Topics: Adolescent; Adult; Aged; Anaplastic Lymphoma Kinase; Antineoplastic Combined Chemotherapy Protocols; | 2012 |
Diffuse large B-cell lymphoma presenting as a sacral tumor. Report of two cases.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy | 2003 |
Interstitial pneumonitis in a patient with melanoma treated with the high dose interferon alpha 2b regimen.
Topics: Anti-Inflammatory Agents; Antineoplastic Agents; Female; Humans; Interferon alpha-2; Interferon-alph | 2004 |
Metastatic malignant melanoma in a patient taking interleukin-1 receptor antagonist.
Topics: Aged; Antimalarials; Arthritis, Rheumatoid; Drug Therapy, Combination; Humans; Interleukin 1 Recepto | 2006 |
Late-onset myopathy and melanotic malignant melanoma.
Topics: Brain Neoplasms; Dexamethasone; Humans; Male; Melanoma; Middle Aged; Muscular Diseases; Myography; P | 1967 |
DTIC (dacarbazine)-induced hepatic damage. Possible pathogenesis and prevention.
Topics: Aged; Alanine Transaminase; Alkaline Phosphatase; Aspartate Aminotransferases; Chemical and Drug Ind | 1981 |
Kidney failure or cancer. Should immunosuppression be continued in a transplant patient with malignant melanoma?
Topics: Adult; Azathioprine; Disease Susceptibility; Female; Glomerulonephritis; Graft Rejection; Humans; Im | 1984 |
[Bladder cancer and malignant melanoma following Endoxan therapy of a lymphoproliferative disease].
Topics: Adenoma; Carcinoma, Squamous Cell; Cervix Uteri; Cyclophosphamide; Drug Therapy, Combination; Female | 1981 |
Interferons up-regulate with different potency HLA class I antigen expression in M14 human melanoma cell line. Possible interaction with glucocorticoid hormones.
Topics: Drug Synergism; Gene Expression; Glucocorticoids; Histocompatibility Antigens Class I; Humans; In Vi | 1995 |
Scleral melt after cryotherapy for conjunctival melanoma.
Topics: Aged; Conjunctival Neoplasms; Cryosurgery; Humans; Male; Melanoma; Melanosis; Postoperative Complica | 1993 |
Excess benign melanocytic naevi in renal transplant recipients.
Topics: Adult; Anti-Inflammatory Agents; Azathioprine; Back; Buttocks; Case-Control Studies; Cyclosporine; F | 1997 |
Presumed choroidal granuloma with vitreous hemorrhage resembling choroidal melanoma.
Topics: Administration, Oral; Adult; Choroid Diseases; Choroid Neoplasms; Diagnosis, Differential; Fluoresce | 1998 |
Paraneoplastic opsoclonus-myoclonus secondary to malignant melanoma.
Topics: Adult; Anti-Inflammatory Agents; Humans; Magnetic Resonance Imaging; Male; Melanoma; Myoclonus; Ocul | 1999 |
Neutrophil-rich Ki-1-positive anaplastic large cell lymphoma: a study by fine-needle aspiration biopsy.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Biopsy, Needle; Carcinoma; Cyclophosphamide; | 2002 |
Cutaneous malignant melanomas occurring under cyclosporin A therapy: a report of two cases.
Topics: Adult; Cyclosporins; Drug Therapy, Combination; Female; Humans; Kidney Transplantation; Male; Melano | 1990 |
Hypercalcemia and reversible renal failure in heavy-chain disease.
Topics: Acute Kidney Injury; Aged; Calcium; Cyclophosphamide; Diagnosis, Differential; Drug Therapy, Combina | 1986 |
Leukocytosis due to adrenal metastases from malignant melanoma: reversal after bilateral adrenalectomy with long-term survival.
Topics: Adrenal Gland Neoplasms; Adrenalectomy; Adult; Combined Modality Therapy; Fludrocortisone; Humans; L | 1988 |
Association of malignant melanoma and malignant lymphoma.
Topics: Biopsy; Cyclophosphamide; Lymphatic Metastasis; Lymphoma; Melanoma; Neoplasm Metastasis; Neoplasm Re | 1973 |
L-asparaginase in the treatment of neoplastic diseases in children.
Topics: Adolescent; Antineoplastic Agents; Asparaginase; Bone Marrow Examination; Bone Neoplasms; Burkitt Ly | 1971 |
The place of the L-asparaginase in the treatment of acute leukemias.
Topics: Acute Disease; Adolescent; Adult; Animals; Asparaginase; Child; Child, Preschool; Chronic Disease; D | 1970 |
Hazard of immunosuppressive therapy.
Topics: Adult; Azathioprine; Female; Humans; Lupus Erythematosus, Systemic; Melanoma; Prednisone | 1972 |
An evaluation of the management of patients with cerebral metastases from malignant melanoma.
Topics: Adult; Aged; Amides; Brain; Brain Neoplasms; Coma; Dexamethasone; Evaluation Studies as Topic; Femal | 1972 |
An unusual malignant melanoma of the choroid affected by prednisone.
Topics: Choroid Neoplasms; Female; Humans; Melanoma; Middle Aged; Prednisone | 1970 |
Hodgkin's disease associated with Kaposi's sarcoma and malignant melanoma. Case report of multiple primary malignancies.
Topics: Aged; Arm; Fingers; Foot; Hand; Hodgkin Disease; Humans; Intestinal Neoplasms; Jejunum; Male; Melano | 1971 |
Bilateral inflammatory pseudotumors of the ciliary body.
Topics: Administration, Topical; Anti-Inflammatory Agents; Atropine; Biopsy; Ciliary Body; Diagnosis, Differ | 1971 |